Ongoing Investigation: Boston Scientific Corporation (BSX) May Have Misled Shareholders - Levi & Korsinsky Investigates
New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of...
2026-02-19 8:20 PM EST
Potential Securities Fraud: Levi & Korsinsky Investigates Hub Group, Inc. (HUBG)
New York, New York--(Newsfile Corp. - February 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Hub Group, Inc. ("Hub Group, Inc.") (NASDAQ: HUBG) concerning potential violations of the federal securities laws. On February 3, 2026, Hub Group reached a 52-week high of $48.96 per share. Three days later, following the accounting error announcement, shares were trading near $37--a loss of roughly $12 per share in a matter of hours. For an investor...
2026-02-18 6:07 PM EST
HUBG Investor Notice: Levi & Korsinsky Investigates Hub Group, Inc. for Securities Law Violations
New York, New York--(Newsfile Corp. - February 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Hub Group, Inc. ("Hub Group, Inc.") (NASDAQ: HUBG) concerning potential violations of the federal securities laws. On February 3, 2026, Hub Group reached a 52-week high of $48.96 per share. Three days later, following the accounting error announcement, shares were trading near $37--a loss of roughly $12 per share in a matter of hours. For an investor...
2026-02-18 5:56 PM EST
IT ALERT: Levi & Korsinsky Investigates Gartner, Inc. on Behalf of Shareholders Who Lost Money
New York, New York--(Newsfile Corp. - February 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. ("Gartner, Inc.") (NYSE: IT) concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that...
2026-02-18 2:52 PM EST
Did You Suffer Losses in ICON Public Limited Company (ICLR)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws. The magnitude of the single-day decline wiped out billions of dollars of shareholder value and represented one of the largest percentage drops in the CRO sector in recent years. Prior to the disclosure, ICLR had traded...
2026-02-17 4:30 PM EST
Lost Investment in Medpace Holdings, Inc. (MEDP)? Levi & Korsinsky Launches Securities Fraud Investigation
New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP) concerning potential violations of the federal securities laws. On February 10, 2026, Medpace shares fell approximately 10% by mid-day and closed down 15.9%, according to data from Quiver Quantitative and GuruFocus. Approximately $10.2 million in trading volume was recorded during the...
2026-02-17 4:26 PM EST
Lost Money on PayPal Holdings, Inc. (PYPL)? Contact Levi & Korsinsky to Protect Your Rights
New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. (NASDAQ: PYPL) ("PayPal Holdings, Inc.") concerning potential violations of the federal securities laws. The timeline of analyst expectations and company communications reveals a notable trajectory. On January 28, 2026, Rothschild & Co Redburn issued a downgrade, cutting PayPal's price target to $50 from $70. The following day, Morgan...
2026-02-17 12:06 AM EST
CORT ALERT: Ongoing Investigation Into Corcept Therapeutics Incorporated - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated") (NASDAQ: CORT) concerning potential violations of the federal securities laws. What Happened? On December 31, 2025, Corcept announced it received a CRL from the FDA, denying approval of Corcept's new drug application for relacorilant as a treatment for patients with hypertension...
2026-02-16 12:39 AM EST
Fraud Investigation Opened: Levi & Korsinsky Investigates PayPal Holdings, Inc. (PYPL) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PayPal Holdings, Inc. ("PayPal Holdings, Inc.") (NASDAQ: PYPL) concerning potential violations of the federal securities laws. The timeline of analyst expectations and company communications reveals a notable trajectory. On January 28, 2026, Rothschild & Co Redburn issued a downgrade, cutting PayPal's price target to $50 from $70. The following day, Morgan...
2026-02-16 12:30 AM EST
Fraud Investigation: Levi & Korsinsky Investigates Ralliant Corporation (RAL) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ralliant Corporation ("Ralliant Corporation") (NYSE: RAL) concerning potential violations of the federal securities laws. On January 30, 2026--five days before revealing a $1.4 billion goodwill impairment and reduced FY 2026 guidance--Ralliant's board of directors declared a regular quarterly dividend of $0.05 per share. Dividend declarations are widely...
2026-02-16 12:26 AM EST
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Commvault Systems, Inc. (CVLT)
New York, New York--(Newsfile Corp. - February 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-16 12:22 AM EST
STLA ACTIVE INVESTIGATION: Lost Money on Stellantis N.V.? Contact Levi & Korsinsky Now
New York, New York--(Newsfile Corp. - February 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Stellantis N.V. ("Stellantis N.V.") (NYSE: STLA) concerning potential violations of the federal securities laws. A review of the timeline highlights a sequence of signals that preceded the February 6 disclosure. On January 31, 2026, Wall Street Zen downgraded STLA to Sell. On February 3, Morgan Stanley followed with a downgrade to Equal-Weight, referencing...
2026-02-13 4:00 PM EST
Levi & Korsinsky Investigates Possible Securities Fraud by Coty Inc. (COTY)
New York, New York--(Newsfile Corp. - February 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Coty Inc. ("Coty Inc.") (NYSE: COTY) concerning potential violations of the federal securities laws. Coty's quarterly loss stands out within the global beauty and personal care sector, an industry that has generally posted resilient consumer demand over the past two years. Peers such as Estée Lauder, L'Oréal, and Shiseido reported stable or improving...
2026-02-11 1:19 PM EST
IT ALERT: Levi & Korsinsky Investigates Gartner, Inc. for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - February 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. ("Gartner, Inc.") (NYSE: IT) concerning potential violations of the federal securities laws. SEC Regulation G and Item 10(e) of Regulation S-K establish disclosure requirements for companies presenting non-GAAP financial measures. These rules require that adjusted metrics be reconciled to the most directly comparable GAAP measure and that...
2026-02-11 8:53 AM EST
Levi & Korsinsky Launches Fraud Investigation on Behalf of monday.com Ltd. (MNDY) Shareholders
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into monday.com Ltd. ("monday.com Ltd.") (NASDAQ: MNDY) concerning potential violations of the federal securities laws. On its February 9, 2026 earnings call, monday.com disclosed two specific headwinds that it had built into its 2026 guidance: persistent weakness in its "no-touch" performance marketing channel serving small and medium businesses, and a 100-200...
2026-02-10 3:20 PM EST
RAL ALERT: Ongoing Investigation Into Ralliant Corporation - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Ralliant Corporation ("Ralliant Corporation") (NYSE: RAL) concerning potential violations of the federal securities laws. On January 30, 2026--five days before revealing a $1.4 billion goodwill impairment and reduced FY 2026 guidance--Ralliant's board of directors declared a regular quarterly dividend of $0.05 per share. Dividend declarations are widely...
2026-02-10 1:24 PM EST
Commvault Systems, Inc. (CVLT) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Commvault Systems, Inc. ("Commvault Systems, Inc.") (NASDAQ: CVLT) concerning potential violations of the federal securities laws. On January 27, 2026, Commvault reported financial results for the third quarter of fiscal 2026 ended December 31, 2025, including "40% growth in SaaS ARR to $364 million," as noted by the Company's Chief Accounting Officer...
2026-02-10 11:34 AM EST
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)
New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific Corporation") concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of...
2026-02-10 1:41 AM EST
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890...
2026-02-09 12:27 AM EST
Ongoing Investigation: REGENXBIO Inc. (RGNX) May Have Misled Shareholders - Levi & Korsinsky Investigates
New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into REGENXBIO Inc. ("REGENXBIO Inc.") (NASDAQ: RGNX) concerning potential violations of the federal securities laws. On January 28, 2026, Regenxbio disclosed via Form 8-K that the FDA placed clinical holds on its RGX-111 and RGX-121 programs following the identification of a tumor in a trial participant. The disclosure prompted a 30-35% decline in the company's...
2026-02-09 12:21 AM EST